2002), angiotensin‐converting enzyme inhibitors (Flather et al. 2000), and angiotensin II receptor blockers (Pitt et al. 2000), are used for therapy of heart failure. Nevertheless, the mortality rate of chronic heart failure remains high, and additional therapeutic strategies need to be developed (Li et al. 2004, 2014). The gene discussed is ACE; the disease is heart failure.